Barclays raised the firm’s price target on Axon (AXON) to $735 from $726 and keeps an Overweight rating on the shares. The company’s strength continued with its 13th consecutive quarter of revenue growth over 25% year-over-year, the analyst tells investors in a research note. The firm says T10 demand continues to outpace current capacity.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AXON: